Roche is set to raise $1.2 billion from the sale of a US biologics manufacturing facility to Swiss contract development and manufacturing organisation (CDMO) Lonza, part of a drive to match ...

Lonza has boosted its ability to cater for customers in the fast-emerging antibody-drug conjugate category with a deal to buy Dutch company Synaffix and its platform technology for designing and ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

(RTTNews) - Lonza Group (LZAGF.PK), a Swiss manufacturer focused on the pharmaceutical and nutrition businesses, on Thursday reported that its third-quarter performance was in line to deliver on ...

In this article, we are going to take a look at where Lonza Group AG (OTC:LZAGY) stands against the other tech based disruptive stocks. When it comes to investing and making massive gains on the ...

Kepler Capital analyst Pablo de Renteria maintained a Buy rating on Lonza Group Ltd (LONN – Research Report) on October 24 and set a price target of CHF630.00. According to TipRanks, de Renteria ...

This study presents valuable insights into the organization of second-order circuits for gustatory neurons, particularly how they integrate opposing taste inputs and the metabolic states that regulate ...

The global electrophoresis market is poised for significant expansion, with market value anticipated to grow from USD 2,268.8 million in 2023 to a projected USD 3,523.5 million by 2033. This robust ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...